{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:01:21Z","timestamp":1790791281947,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T00:00:00Z","timestamp":1464566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11914-016-0311-6","type":"journal-article","created":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T05:33:28Z","timestamp":1464586408000},"page":"126-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations"],"prefix":"10.1007","volume":"14","author":[{"given":"Ernesto","family":"Canalis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Zanotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,30]]},"reference":[{"issue":"9","key":"311_CR1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","volume":"357","author":"E Canalis","year":"2007","unstructured":"Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med. 2007;357(9):905\u201316. A review on anabolic mechanisms and treatment for osteoporosis.","journal-title":"N Engl J Med"},{"issue":"19","key":"311_CR2","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMe058080","volume":"352","author":"E Canalis","year":"2005","unstructured":"Canalis E. The fate of circulating osteoblasts. N Engl J Med. 2005;352(19):2014\u20136.","journal-title":"N Engl J Med"},{"issue":"9","key":"311_CR3","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1359\/jbmr.2001.16.9.1583","volume":"16","author":"AM Parfitt","year":"2001","unstructured":"Parfitt AM. The bone remodeling compartment: a circulatory function for bone lining cells. J Bone Miner Res. 2001;16(9):1583\u20135.","journal-title":"J Bone Miner Res"},{"issue":"21","key":"311_CR4","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","volume":"354","author":"E Seeman","year":"2006","unstructured":"Seeman E, Delmas PD. Bone quality\u2014the material and structural basis of bone strength and fragility. N Engl J Med. 2006;354(21):2250\u201361.","journal-title":"N Engl J Med"},{"key":"311_CR5","first-page":"481","volume":"3","author":"NA Sims","year":"2014","unstructured":"Sims NA, Martin TJ. Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. Bonekey Rep. 2014;3:481.","journal-title":"Bonekey Rep."},{"issue":"7","key":"311_CR6","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/jbmr.2276","volume":"29","author":"TJ Martin","year":"2014","unstructured":"Martin TJ. Coupling factors: how many candidates can there be? J Bone Miner Res. 2014;29(7):1519\u201321.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"311_CR7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2353\/ajpath.2007.060834","volume":"170","author":"SL Teitelbaum","year":"2007","unstructured":"Teitelbaum SL. Osteoclasts: what do they do and how do they do it? Am J Pathol. 2007;170(2):427\u201335.","journal-title":"Am J Pathol"},{"issue":"10","key":"311_CR8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrendo.2013.154","volume":"9","author":"E Canalis","year":"2013","unstructured":"Canalis E. Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches. Nat Rev Endocrinol. 2013;9(10):575\u201383. A comprehensive review of Wnt signaling in the skeleton and associated clinical disorders.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"311_CR9","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1210\/er.2002-0023","volume":"24","author":"E Canalis","year":"2003","unstructured":"Canalis E, Economides AN, Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev. 2003;24(2):218\u201335.","journal-title":"Endocr Rev"},{"issue":"1-2","key":"311_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11154-006-9000-6","volume":"7","author":"E Gazzerro","year":"2006","unstructured":"Gazzerro E, Canalis E. Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord. 2006;7(1-2):51\u201365.","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"311_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2011.10.044","volume":"492","author":"DG Monroe","year":"2012","unstructured":"Monroe DG, McGee-Lawrence ME, Oursler MJ, Westendorf JJ. Update on Wnt signaling in bone cell biology and bone disease. Gene. 2012;492(1):1\u201318.","journal-title":"Gene"},{"issue":"4","key":"311_CR12","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/MCB.01285-09","volume":"30","author":"S Zanotti","year":"2010","unstructured":"Zanotti S, Canalis E. Notch and the skeleton. Mol Cell Biol. 2010;30(4):886\u201396.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"311_CR13","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1530\/EJE-13-0115","volume":"168","author":"S Zanotti","year":"2013","unstructured":"Zanotti S, Canalis E. Notch signaling in skeletal health and disease. Eur J Endocrinol. 2013;168(6):R95\u2013R103.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"311_CR14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","volume":"34","author":"SL Dallas","year":"2013","unstructured":"Dallas SL, Prideaux M, Bonewald LF. The osteocyte: an endocrine cell \u2026 more. Endocr Rev. 2013;34(5):658\u201390.","journal-title":"Endocr Rev"},{"issue":"12","key":"311_CR15","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/MCB.01428-09","volume":"30","author":"I Kramer","year":"2010","unstructured":"Kramer I, Halleux C, Keller H, Pegurri M, Gooi JH, Weber PB, et al. Osteocyte Wnt\/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol. 2010;30(12):3071\u201385.","journal-title":"Mol Cell Biol"},{"issue":"10","key":"311_CR16","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","volume":"17","author":"T Nakashima","year":"2011","unstructured":"Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011;17(10):1231\u20134.","journal-title":"Nat Med"},{"issue":"42","key":"311_CR17","doi-asserted-by":"crossref","first-page":"31720","DOI":"10.1074\/jbc.M602308200","volume":"281","author":"JA Robinson","year":"2006","unstructured":"Robinson JA, Chatterjee-Kishore M, Yaworsky PJ, Cullen DM, Zhao W, Li C, et al. Wnt\/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J Biol Chem. 2006;281(42):31720\u20138.","journal-title":"J Biol Chem"},{"issue":"10","key":"311_CR18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm.2448","volume":"17","author":"J Xiong","year":"2011","unstructured":"Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O\u2019Brien CA. Matrix-embedded cells control osteoclast formation. Nat Med. 2011;17(10):1235\u201341.","journal-title":"Nat Med"},{"issue":"2","key":"311_CR19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00223-011-9541-x","volume":"90","author":"S Zanotti","year":"2012","unstructured":"Zanotti S, Canalis E. Notch regulation of bone development and remodeling and related skeletal disorders. Calcif Tissue Int. 2012;90(2):69\u201375.","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"311_CR20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.devcel.2009.03.010","volume":"16","author":"ME Fortini","year":"2009","unstructured":"Fortini ME. Notch signaling: the core pathway and its posttranslational regulation. Dev Cell. 2009;16(5):633\u201347.","journal-title":"Dev Cell"},{"issue":"5","key":"311_CR21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.sbi.2007.09.007","volume":"17","author":"P Stanley","year":"2007","unstructured":"Stanley P. Regulation of Notch signaling by glycosylation. Curr Opin Struct Biol. 2007;17(5):530\u20135.","journal-title":"Curr Opin Struct Biol"},{"issue":"2","key":"311_CR22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/dbio.2000.9960","volume":"228","author":"JS Mumm","year":"2000","unstructured":"Mumm JS, Kopan R. Notch signaling: from the outside in. Dev Biol. 2000;228(2):151\u201365.","journal-title":"Dev Biol"},{"issue":"38","key":"311_CR23","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1038\/onc.2008.223","volume":"27","author":"RA Kovall","year":"2008","unstructured":"Kovall RA. More complicated than it looks: assembly of Notch pathway transcription complexes. Oncogene. 2008;27(38):5099\u2013109.","journal-title":"Oncogene"},{"issue":"5","key":"311_CR24","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cell.2005.12.037","volume":"124","author":"Y Nam","year":"2006","unstructured":"Nam Y, Sliz P, Song L, Aster JC, Blacklow SC. Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. Cell. 2006;124(5):973\u201383.","journal-title":"Cell"},{"issue":"6683","key":"311_CR25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/30756","volume":"393","author":"EH Schroeter","year":"1998","unstructured":"Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature. 1998;393(6683):382\u20136.","journal-title":"Nature"},{"issue":"5","key":"311_CR26","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2006.01.035","volume":"124","author":"JJ Wilson","year":"2006","unstructured":"Wilson JJ, Kovall RA. Crystal structure of the CSL-Notch-mastermind ternary complex bound to DNA. Cell. 2006;124(5):985\u201396. Initial report describing the structure of the Notch transcriptional complex.","journal-title":"Cell"},{"issue":"3","key":"311_CR27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jcp.10208","volume":"194","author":"T Iso","year":"2003","unstructured":"Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol. 2003;194(3):237\u201355.","journal-title":"J Cell Physiol"},{"issue":"2","key":"311_CR28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","volume":"137","author":"R Kopan","year":"2009","unstructured":"Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216\u201333.","journal-title":"Cell"},{"issue":"10","key":"311_CR29","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1074\/jbc.M707000200","volume":"283","author":"S Bai","year":"2008","unstructured":"Bai S, Kopan R, Zou W, Hilton MJ, Ong CT, Long F, et al. NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells. J Biol Chem. 2008;283(10):6509\u201318.","journal-title":"J Biol Chem"},{"issue":"1","key":"311_CR30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S8756-3282(99)00099-X","volume":"25","author":"DJ Dallas","year":"1999","unstructured":"Dallas DJ, Genever PG, Patton AJ, Millichip MI, McKie N, Skerry TM. Localization of ADAM10 and Notch receptors in bone. Bone. 1999;25(1):9\u201315.","journal-title":"Bone"},{"issue":"2","key":"311_CR31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jcb.10125","volume":"85","author":"RM Pereira","year":"2002","unstructured":"Pereira RM, Delany AM, Durant D, Canalis E. Cortisol regulates the expression of Notch in osteoblasts. J Cell Biochem. 2002;85(2):252\u20138.","journal-title":"J Cell Biochem"},{"issue":"3","key":"311_CR32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nm1712","volume":"14","author":"F Engin","year":"2008","unstructured":"Engin F, Yao Z, Yang T, Zhou G, Bertin T, Jiang MM, et al. Dimorphic effects of Notch signaling in bone homeostasis. Nat Med. 2008;14(3):299\u2013305.","journal-title":"Nat Med"},{"issue":"3","key":"311_CR33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nm1716","volume":"14","author":"MJ Hilton","year":"2008","unstructured":"Hilton MJ, Tu X, Wu X, Bai S, Zhao H, Kobayashi T, et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med. 2008;14(3):306\u201314.","journal-title":"Nat Med"},{"issue":"8","key":"311_CR34","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1210\/en.2008-0140","volume":"149","author":"S Zanotti","year":"2008","unstructured":"Zanotti S, Smerdel-Ramoya A, Stadmeyer L, Durant D, Radtke F, Canalis E. Notch inhibits osteoblast differentiation and causes osteopenia. Endocrinology. 2008;149(8):3890\u20139.","journal-title":"Endocrinology"},{"issue":"9","key":"311_CR35","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1242\/dev.042911","volume":"137","author":"Y Dong","year":"2010","unstructured":"Dong Y, Jesse AM, Kohn A, Gunnell LM, Honjo T, Zuscik MJ, et al. RBPjkappa-dependent Notch signaling regulates mesenchymal progenitor cell proliferation and differentiation during skeletal development. Development. 2010;137(9):1461\u201371.","journal-title":"Development"},{"issue":"4","key":"311_CR36","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/dvdy.20590","volume":"234","author":"JC Francis","year":"2005","unstructured":"Francis JC, Radtke F, Logan MP. Notch1 signals through Jagged2 to regulate apoptosis in the apical ectodermal ridge of the developing limb bud. Dev Dyn. 2005;234(4):1006\u201315.","journal-title":"Dev Dyn"},{"issue":"6","key":"311_CR37","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/dvdy.21114","volume":"236","author":"R Kageyama","year":"2007","unstructured":"Kageyama R, Masamizu Y, Niwa Y. Oscillator mechanism of Notch pathway in the segmentation clock. Dev Dyn. 2007;236(6):1403\u20139.","journal-title":"Dev Dyn"},{"issue":"4","key":"311_CR38","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1074\/jbc.M110.183038","volume":"286","author":"S Zanotti","year":"2011","unstructured":"Zanotti S, Smerdel-Ramoya A, Canalis E. Hairy and enhancer of split (HES)1 is a determinant of bone mass. J Biol Chem. 2011;286(4):2648\u201357.","journal-title":"J Biol Chem"},{"issue":"6","key":"311_CR39","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/hmg\/ddr575","volume":"21","author":"R Humphreys","year":"2012","unstructured":"Humphreys R, Zheng W, Prince LS, Qu X, Brown C, Loomes K, et al. Cranial neural crest ablation of Jagged1 recapitulates the craniofacial phenotype of Alagille syndrome patients. Hum Mol Genet. 2012;21(6):1374\u201383.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"311_CR40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/jbmr.2591","volume":"31","author":"AH Jheon","year":"2016","unstructured":"Jheon AH, Prochazkova M, Meng B, Wen T, Lim YJ, Naveau A, et al. Inhibition of notch signaling during mouse incisor renewal leads to enamel defects. J Bone Miner Res. 2016;31(1):152\u201362.","journal-title":"J Bone Miner Res"},{"issue":"241","key":"311_CR41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1259\/0007-1285-21-241-42","volume":"21","author":"N Hajdu","year":"1948","unstructured":"Hajdu N, Kauntze R. Cranio-skeletal dysplasia. Br J Radiol. 1948;21(241):42\u20138. Original description of Hajdu Cheney Syndrome.","journal-title":"Br J Radiol"},{"key":"311_CR42","first-page":"595","volume":"94","author":"WD Cheney","year":"1965","unstructured":"Cheney WD. Acro-osteolysis. Am J Roentgenol Radium Ther Nucl Med. 1965;94:595\u2013607. Description of Hajdu Cheney as a syndrome.","journal-title":"Am J Roentgenol Radium Ther Nucl Med."},{"issue":"1","key":"311_CR43","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13023-014-0200-y","volume":"9","author":"E Canalis","year":"2014","unstructured":"Canalis E, Zanotti S. Hajdu-Cheney syndrome: a review. Orphanet J Rare Dis. 2014;9(1):200.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"311_CR44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MCD.0000000000000034","volume":"23","author":"M Descartes","year":"2014","unstructured":"Descartes M, Rojnueangnit K, Cole L, Sutton A, Morgan SL, Patry L, et al. Hajdu-Cheney syndrome: phenotypical progression with de-novo NOTCH2 mutation. Clin Dysmorphol. 2014;23(3):88\u201394. Comprehensive description of clinical features of Hajdu Cheney Syndrome.","journal-title":"Clin Dysmorphol"},{"issue":"2","key":"311_CR45","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1210\/en.2012-1925","volume":"154","author":"S Zanotti","year":"2013","unstructured":"Zanotti S, Canalis E. Notch suppresses nuclear factor of activated T cells (Nfat) transactivation and Nfatc1 expression in chondrocytes. Endocrinology. 2013;154(2):762\u201372.","journal-title":"Endocrinology"},{"issue":"6","key":"311_CR46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.kjms.2012.10.009","volume":"29","author":"G Sargin","year":"2013","unstructured":"Sargin G, Cildag S, Senturk T. Hajdu-Cheney syndrome with ventricular septal defect. Kaohsiung J Med Sci. 2013;29(6):343\u20134.","journal-title":"Kaohsiung J Med Sci"},{"key":"311_CR47","first-page":"43","volume":"4","author":"SG Kaler","year":"1990","unstructured":"Kaler SG, Geggel RL, Sadeghi-Nejad A. Hajdu-Cheney syndrome associated with severe cardiac valvular and conduction disease. Dysmorph Clin Genet. 1990;4:43\u20137.","journal-title":"Dysmorph Clin Genet"},{"issue":"4","key":"311_CR48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1242\/dev.128.4.491","volume":"128","author":"B McCright","year":"2001","unstructured":"McCright B, Gao X, Shen L, Lozier J, Lan Y, Maguire M, et al. Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development. 2001;128(4):491\u2013502.","journal-title":"Development"},{"issue":"1","key":"311_CR49","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ejhg.2011.125","volume":"20","author":"MJ Gray","year":"2012","unstructured":"Gray MJ, Kim CA, Bertola DR, Arantes PR, Stewart H, Simpson MA, et al. Serpentine fibula polycystic kidney syndrome is part of the phenotypic spectrum of Hajdu-Cheney syndrome. Eur J Hum Genet. 2012;20(1):122\u20134.","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"311_CR50","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/humu.21563","volume":"32","author":"B Isidor","year":"2011","unstructured":"Isidor B, Le MM, Exner GU, Pichon O, Thierry G, Guiochon-Mantel A, et al. Serpentine fibula-polycystic kidney syndrome caused by truncating mutations in NOTCH2. Hum Mutat. 2011;32(11):1239\u201342.","journal-title":"Hum Mutat"},{"issue":"11","key":"311_CR51","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/BF01957530","volume":"152","author":"F Majewski","year":"1993","unstructured":"Majewski F, Enders H, Ranke MB, Voit T. Serpentine fibula\u2014polycystic kidney syndrome and Melnick-needles syndrome are different disorders. Eur J Pediatr. 1993;152(11):916\u201321.","journal-title":"Eur J Pediatr"},{"key":"311_CR52","doi-asserted-by":"crossref","unstructured":"Isidor B, Lindenbaum P, Pichon O, Bezieau S, Dina C, Jacquemont S, et al. Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis. Nat Genet. 2011;43(4):306\u20138. First description of an association of NOTCH2 mutations with Hajdu Cheney Syndrome.","DOI":"10.1038\/ng.778"},{"issue":"10","key":"311_CR53","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/humu.21546","volume":"32","author":"J Majewski","year":"2011","unstructured":"Majewski J, Schwartzentruber JA, Caqueret A, Patry L, Marcadier J, Fryns JP, et al. Mutations in NOTCH2 in families with Hajdu-Cheney syndrome. Hum Mutat. 2011;32(10):1114\u20137.","journal-title":"Hum Mutat"},{"key":"311_CR54","doi-asserted-by":"crossref","unstructured":"Simpson MA, Irving MD, Asilmaz E, Gray MJ, Dafou D, Elmslie FV, et al. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss. Nat Genet. 2011;43(4):303\u20135. First description of an association of NOTCH2 mutations with Hajdu Cheney Syndrome.","DOI":"10.1038\/ng.779"},{"issue":"8","key":"311_CR55","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00198-013-2298-5","volume":"24","author":"W Zhao","year":"2013","unstructured":"Zhao W, Petit E, Gafni RI, Collins MT, Robey PG, Seton M, et al. Mutations in NOTCH2 in patients with Hajdu-Cheney syndrome. Osteoporos Int. 2013;24(8):2275\u201381.","journal-title":"Osteoporos Int"},{"key":"311_CR56","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1074\/jbc.M115.685453","volume":"291","author":"E Canalis","year":"2016","unstructured":"Canalis E, Schilling L, Yee SP, Lee SK, Zanotti S. Hajdu Cheney mouse mutants exhibit osteopenia, increased osteoclastogenesis and bone resorption. J Biol Chem. 2016;291:1538\u201351. First description of a mouse model of Hajdu Cheney Syndrome.","journal-title":"J Biol Chem."},{"issue":"4","key":"311_CR57","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0002-9343(78)90851-3","volume":"65","author":"AN Elias","year":"1978","unstructured":"Elias AN, Pinals RS, Anderson HC, Gould LV, Streeten DH. Hereditary osteodysplasia with acro-osteolysis. (The Hajdu-Cheney syndrome). Am J Med. 1978;65(4):627\u201336.","journal-title":"Am J Med"},{"issue":"3","key":"311_CR58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF03349553","volume":"13","author":"V Nunziata","year":"1990","unstructured":"Nunziata V, di GG, Ballanti P, Bonucci E. High turnover osteoporosis in acro-osteolysis (Hajdu-Cheney syndrome). J Endocrinol Invest. 1990;13(3):251\u20135.","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"311_CR59","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/art.1780290815","volume":"29","author":"J Udell","year":"1986","unstructured":"Udell J, Schumacher Jr HR, Kaplan F, Fallon MD. Idiopathic familial acroosteolysis: histomorphometric study of bone and literature review of the Hajdu-Cheney syndrome. Arthritis Rheum. 1986;29(8):1032\u20138.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"311_CR60","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/ajmg.a.33510","volume":"155A","author":"K Avela","year":"2011","unstructured":"Avela K, Valanne L, Helenius I, Makitie O. Hajdu-Cheney syndrome with severe dural ectasia. Am J Med Genet A. 2011;155A(3):595\u20138.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"311_CR61","first-page":"574","volume":"20","author":"BT Blumenauer","year":"2002","unstructured":"Blumenauer BT, Cranney AB, Goldstein R. Acro-osteolysis and osteoporosis as manifestations of the Hajdu-Cheney syndrome. Clin Exp Rheumatol. 2002;20(4):574\u20135.","journal-title":"Clin Exp Rheumatol"},{"issue":"4 Pt 1","key":"311_CR62","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0022-3476(76)80009-1","volume":"88","author":"DM Brown","year":"1976","unstructured":"Brown DM, Bradford DS, Gorlin RJ, Desnick RJ, Langer LO, Jowsey J, et al. The acro-osteolysis syndrome: morphologic and biochemical studies. J Pediatr. 1976;88(4 Pt 1):573\u201380.","journal-title":"J Pediatr"},{"issue":"12","key":"311_CR63","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1359\/jbmr.1999.14.12.2036","volume":"14","author":"G Leidig-Bruckner","year":"1999","unstructured":"Leidig-Bruckner G, Pfeilschifter J, Penning N, Limberg B, Priemel M, Delling G, et al. Severe osteoporosis in familial Hajdu-Cheney syndrome: progression of acro-osteolysis and osteoporosis during long-term follow-up. J Bone Miner Res. 1999;14(12):2036\u201341.","journal-title":"J Bone Miner Res"},{"issue":"20","key":"311_CR64","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1128\/MCB.00299-08","volume":"28","author":"H Fukushima","year":"2008","unstructured":"Fukushima H, Nakao A, Okamoto F, Shin M, Kajiya H, Sakano S, et al. The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis. Mol Cell Biol. 2008;28(20):6402\u201312. Report of direct actions of Notch2 on osteoclast formation.","journal-title":"Mol Cell Biol"},{"issue":"9","key":"311_CR65","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","volume":"209","author":"MJ Kiel","year":"2012","unstructured":"Kiel MJ, Velusamy T, Betz BL, Zhao L, Weigelin HG, Chiang MY, et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med. 2012;209(9):1553\u201365.","journal-title":"J Exp Med"},{"issue":"5","key":"311_CR66","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1349-7006.2009.01130.x","volume":"100","author":"SY Lee","year":"2009","unstructured":"Lee SY, Kumano K, Nakazaki K, Sanada M, Matsumoto A, Yamamoto G, et al. Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma. Cancer Sci. 2009;100(5):920\u20136.","journal-title":"Cancer Sci"},{"issue":"9","key":"311_CR67","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","volume":"209","author":"D Rossi","year":"2012","unstructured":"Rossi D, Trifonov V, Fangazio M, Bruscaggin A, Rasi S, Spina V, et al. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med. 2012;209(9):1537\u201351.","journal-title":"J Exp Med"},{"issue":"24","key":"311_CR68","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1182\/blood-2010-12-325944","volume":"118","author":"F Hampel","year":"2011","unstructured":"Hampel F, Ehrenberg S, Hojer C, Draeseke A, Marschall-Schroter G, Kuhn R, et al. CD19-independent instruction of murine marginal zone B-cell development by constitutive Notch2 signaling. Blood. 2011;118(24):6321\u201331.","journal-title":"Blood"},{"issue":"6","key":"311_CR69","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.171.6.2783","volume":"171","author":"CM Witt","year":"2003","unstructured":"Witt CM, Won WJ, Hurez V, Klug CA. Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells. J Immunol. 2003;171(6):2783\u20138.","journal-title":"J Immunol"},{"issue":"3","key":"311_CR70","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/ajmg.a.35772","volume":"161a","author":"Y Narumi","year":"2013","unstructured":"Narumi Y, Min BJ, Shimizu K, Kazukawa I, Sameshima K, Nakamura K, et al. Clinical consequences in truncating mutations in exon 34 of NOTCH2: report of six patients with Hajdu-Cheney syndrome and a patient with serpentine fibula polycystic kidney syndrome. Am J Med Genet A. 2013;161a(3):518\u201326.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"311_CR71","first-page":"283","volume":"37","author":"A Galli-Tsinopoulou","year":"2012","unstructured":"Galli-Tsinopoulou A, Kyrgios I, Giza S, Giannopoulou EM, Maggana I, Laliotis N. Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome. Minerva Endocrinol. 2012;37(3):283\u20139.","journal-title":"Minerva Endocrinol"},{"issue":"3","key":"311_CR72","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00198-007-0461-6","volume":"19","author":"FE McKiernan","year":"2008","unstructured":"McKiernan FE. Integrated anti-remodeling and anabolic therapy for the osteoporosis of Hajdu-Cheney syndrome: 2-year follow-up. Osteoporos Int. 2008;19(3):379\u201380.","journal-title":"Osteoporos Int"},{"issue":"8","key":"311_CR73","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/hmg\/ddp057","volume":"18","author":"F Engin","year":"2009","unstructured":"Engin F, Bertin T, Ma O, Jiang MM, Wang L, Sutton RE, et al. Notch signaling contributes to the pathogenesis of human osteosarcomas. Hum Mol Genet. 2009;18(8):1464\u201370.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"311_CR74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ccr.2014.07.023","volume":"26","author":"J Tao","year":"2014","unstructured":"Tao J, Jiang MM, Jiang L, Salvo JS, Zeng HC, Dawson B, et al. Notch activation as a driver of osteogenic sarcoma. Cancer Cell. 2014;26(3):390\u2013401.","journal-title":"Cancer Cell"},{"issue":"3","key":"311_CR75","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bone.2006.03.002","volume":"39","author":"JM Weber","year":"2006","unstructured":"Weber JM, Forsythe SR, Christianson CA, Frisch BJ, Gigliotti BJ, Jordan CT, et al. Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells. Bone. 2006;39(3):485\u201393.","journal-title":"Bone"},{"issue":"7270","key":"311_CR76","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature08543","volume":"462","author":"RE Moellering","year":"2009","unstructured":"Moellering RE, Cornejo M, Davis TN, Del BC, Aster JC, Blacklow SC, et al. Direct inhibition of the NOTCH transcription factor complex. Nature. 2009;462(7270):182\u20138.","journal-title":"Nature"},{"issue":"2","key":"311_CR77","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1172\/JCI45976","volume":"121","author":"SW Ryeom","year":"2011","unstructured":"Ryeom SW. The cautionary tale of side effects of chronic Notch1 inhibition. J Clin Invest. 2011;121(2):508\u20139.","journal-title":"J Clin Invest"},{"issue":"7291","key":"311_CR78","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nature08878","volume":"464","author":"Y Wu","year":"2010","unstructured":"Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de Leon GP, Chen Y, et al. Therapeutic antibody targeting of individual Notch receptors. Nature. 2010;464(7291):1052\u20137.","journal-title":"Nature"},{"issue":"7282","key":"311_CR79","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1038\/nature08751","volume":"463","author":"M Yan","year":"2010","unstructured":"Yan M, Callahan CA, Beyer JC, Allamneni KP, Zhang G, Ridgway JB, et al. Chronic DLL4 blockade induces vascular neoplasms. Nature. 2010;463(7282):E6\u20137.","journal-title":"Nature"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-016-0311-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-016-0311-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-016-0311-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T20:41:47Z","timestamp":1656621707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-016-0311-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,30]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["311"],"URL":"https:\/\/doi.org\/10.1007\/s11914-016-0311-6","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,30]]}}}